Michelle Armstrong
Laboratory Manager
Last active: 3/29/2013

Michelle D Armstrong, B.A.

Profile

Laboratory Manager, H. Alex Brown Laboratory Department of Pharmacology, Vanderbilt University Medical Center

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Cobalt carbonyl complexes as probes for alkyne-tagged lipids. Tallman KA, Armstrong MD, Milne SB, Marnett LJ, Brown HA, Porter NA (2013) J Lipid Res 54(3): 859-68
    › Primary publication · 23307946 (PubMed) · PMC3617960 (PubMed Central)
  2. Capture and release of alkyne-derivatized glycerophospholipids using cobalt chemistry. Milne SB, Tallman KA, Serwa R, Rouzer CA, Armstrong MD, Marnett LJ, Lukehart CM, Porter NA, Brown HA (2010) Nat Chem Biol 6(3): 205-207
    › Primary publication · 20098428 (PubMed) · PMC2822082 (PubMed Central)
  3. Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity. Lavieri R, Scott SA, Lewis JA, Selvy PE, Armstrong MD, Alex Brown H, Lindsley CW (2009) Bioorg Med Chem Lett 19(8): 2240-3
    › Primary publication · 19299128 (PubMed) · PMC3800051 (PubMed Central)
  4. Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity. Lewis JA, Scott SA, Lavieri R, Buck JR, Selvy PE, Stoops SL, Armstrong MD, Brown HA, Lindsley CW (2009) Bioorg Med Chem Lett 19(7): 1916-20
    › Primary publication · 19268584 (PubMed) · PMC3791604 (PubMed Central)
  5. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA (2009) Nat Chem Biol 5(2): 108-17
    › Primary publication · 19136975 (PubMed) · PMC3798018 (PubMed Central)
  6. Dramatic differences in the roles in lipid metabolism of two isoforms of diacylglycerol kinase. Milne SB, Ivanova PT, Armstrong MD, Myers DS, Lubarda J, Shulga YV, Topham MK, Brown HA, Epand RM (2008) Biochemistry 47(36): 9372-9
    › Primary publication · 18702510 (PubMed) · PMC2744458 (PubMed Central)
  7. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Sun Y, Fang Y, Yoon MS, Zhang C, Roccio M, Zwartkruis FJ, Armstrong M, Brown HA, Chen J (2008) Proc Natl Acad Sci U S A 105(24): 8286-91
    › Primary publication · 18550814 (PubMed) · PMC2448829 (PubMed Central)

Featured Affiliation

View all affiliations

Contact Information

2220 Pierce Avenue
412A Preston Research Building
Nashville, TN 37232-6600
United States
(615) 936-3887 (p)
(615) 936-6833 (f)
Email

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword

Alkynes Animals Biological Transport Breast Neoplasms Cancer Cell Line Cell Line, Transformed Cell Signaling Cell Transformation, Viral Cobalt Diacylglycerol (DAG) Dose-Response Relationship, Drug Drug Design Drug Discovery Fibroblasts Glycerophospholipids Humans Influenza Isoenzymes Lipidomics Membrane Lipids Metabolomics Mice Mice, Knockout Monomeric GTP-Binding Proteins Neoplasm Invasiveness Neuropeptides Phosphatidic Acid (PA) Phospholipase D Phospholipase D (PLD) Protein Isoforms Protein Kinases RNA Interference Simian virus 40 Structure-Activity Relationship Substrate Specificity TOR Serine-Threonine Kinases Tuberous Sclerosis Complex 1 Protein Tuberous Sclerosis Complex 2 Protein Tumor Suppressor Proteins